Recruiting

An Ecological Momentary Assessment Based Program to Support Self-Management for Post-stroke Patients

ClinicalTrials.gov IDNCT07691411

PhaseNA

Enrollment50

SponsorThe Hong Kong Polytechnic University

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Stroke, Post Stroke

About this study

The goal of this feasibility study is to test whether a new approach that combines real-time symptom tracking (Ecological Momentary Assessment) with machine learning can help people recovering from a stroke to better manage depression, thinking difficulties, and daily functioning. The main questions it aims to answer are: Is this combined approach practical and acceptable for post-stroke survivors? Does the program improve mood, cognitive function, or functional ability to carry out daily activities? Participants will: Use a smartphone app called RehabCare Companion for a period of time Answer brief daily surveys about their mood, thoughts, and activities for one week Receive personalized self-care suggestions generated by machine learning based on their responses Complete assessments of depression, cognition, and functioning before and after the program Take part in a group interview to share their experiences

Interventions

Behavioral: Ecological Momentary Assessment based Self-management Program — The research team collects participants' EMA data (ie., depression, cognitive function, daily activity, and contextual data) from participants for 7-day and analyze the data by machine learning in the first phase, while provide real-time, individualized, self-care messages to the participants via a personalized self-care AI app in the second phase.

Primary outcomes

Feasibility of the study: acceptance (Immediately after the intervention (T2).)
Feasibility of the study: adherence (Immediately after the intervention (T2).)
Feasibility of the study: experience of the participants in using the app (Immediately after the intervention (T2).)

Eligibility information

Inclusion Criteria: * adults aged 18 years or older * having a confirmed diagnosis of stroke * having sufficient proficiency in Cantonese to understand and respond to the assessments and prompts * having a Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) score of 18 or higher * having a smartphone. Exclusion Criteria: * they have moderate to severe cognitive impairment (a HK-MoCA score of 17 or lower) * they have active psychiatric disorders other than depression (e.g., schizophrenia, bipolar disorder) * they have a terminal illness or prognosis that suggests a limited life expectancy * they have conditions that compromise their self-care ability (i.e., bedbound).

Study locations

Queen Elizabeth Hospital, Hong Kong, Hong Kong 999077 Hong Kong

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.